What is Abbott Laboratories's forward P/E?

Abbott Laboratories's forward P/E is 19.68: today's price over the analysts' average EPS estimate for the next twelve months, the earnings expected rather than those reported. By fiscal year, it trades at 20.9 times its FY2026 earnings and 19.5 times its FY2027 earnings.

What is Abbott Laboratories's PEG ratio?

Abbott Laboratories's PEG ratio is 2.61: its P/E of 42.80 over the 16.4% a year the analysts expect its earnings per share to grow from FY2025 to FY2030. Around 1 is often read as a P/E in line with the growth; above it, the price asks for more.

Abbott Laboratories
D
Quotes are delayed by 15 minutes

ABT

Arincen ScoreBeta83/100

83/100B

115.550

USD

6.14

(5.61%)

Post Trading·115.230USD-0.320(-0.28%)

Last updated: 4 Nov, 16:50 GMT-5 · Delayed 15 min

Fair valueNot reliable

Q4 FY2026 · Earnings report

EPS estimate 1.64Revenue estimate 13.22B

Q4 FY2026 · Earnings report

Thursday 28 January

EPS estimate 1.64Revenue estimate 13.22B

Fair valueNot reliable

Q4 FY2026 · Earnings report

EPS estimate 1.64Revenue estimate 13.22B

Q4 FY2026 · Earnings report

Thursday 28 January

EPS estimate 1.64Revenue estimate 13.22B

Overview Financials Signals News Forecast Earnings Dividends Company

Abbott Laboratories P/E ratio

Abbott Laboratories's P/E ratio is 42.80: its share price of 115.55 over its earnings per share of 2.70 over the last twelve months.

Today: 42.80
Forward P/E, next 12 months: 19.68
PEG ratio: 2.61
Median, 5 years: 29.72
Low, 5 years: 13.18
High, 5 years: 42.80

P/E ratio = price ÷ EPS (last 12 months) = 115.55 ÷ 2.70 = 42.80

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Abbott Laboratories's P/E high compared with its own history?

Abbott Laboratories's P/E of 42.8 is near the top of its 5-year range (13.2 to 42.8, median 29.7). It is within 5% of its 5-year high. Analysts expect faster growth than in recent years, which can explain part of the high P/E.

5-year range of the daily P/E

Median 29.7

Today 42.8

13.2

42.8

The price against its P/E range

At its 5-year high P/E (42.8)At its median P/E (29.7)At its 5-year low P/E (13.2)Price

Each line is the earnings per share of the day times one P/E of the last five years: the price near the top line is near the most it was paid for those earnings, near the bottom line the least.

Growth a year: the past against what analysts expect

EPSFaster
Expected, to FY2028 20.5%Past 5 years 8.3%Past 3 years -1.6%
RevenueFaster
Expected, to FY2028 8.8%Past 5 years 5.1%Past 3 years 0.5%

	Past 5 years	Past 3 years	Expected, to FY2028	Expected against the past
EPS	8.3%	-1.6%	20.5%	Faster
Revenue	5.1%	0.5%	8.8%	Faster

Buyers pay less for each point of growth than usual: a PEG of 2.1 on expected growth against 3.6 on its median P/E and past five years' growth.

What changed in 5 years

Debt is lower than in FY2020: 1.3 times EBITDA against 2.2.
Operating margin is higher than in FY2020: ⁦18.2%⁩ against ⁦15.3%⁩.
Unusual tax: FY2024 at ⁦-91.1%⁩, FY2025 at ⁦22.9%⁩ against a usual ⁦14.0%⁩, which moves that year's profit and the P/E readings that include it.
Medical Devices grew from ⁦34.1%⁩ of revenue in FY2020 to ⁦48.3%⁩ in FY2025.
Since 5 November 2021 the price has changed ⁦−7.1%⁩: earnings per share ⁦−34.0%⁩ and the P/E ⁦+40.8%⁩.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal year	Period ending	P/E ratio
Today		42.80
FY2025	31 Dec 2025	33.55
FY2024	31 Dec 2024	14.62
FY2023	31 Dec 2023	33.35
FY2022	31 Dec 2022	27.76
FY2021	31 Dec 2021	35.33
FY2020	31 Dec 2020	43.19
FY2019	31 Dec 2019	41.65
FY2018	31 Dec 2018	53.62
FY2017	31 Dec 2017	208.61
FY2016	31 Dec 2016	41.14
FY2015	31 Dec 2015	41.78
FY2014	31 Dec 2014	29.72
FY2013	31 Dec 2013	23.04
FY2012	31 Dec 2012	8.29
FY2011	31 Dec 2011	8.86
FY2010	31 Dec 2010	7.66
FY2009	31 Dec 2009	6.95
FY2008	31 Dec 2008	8.33
FY2007	31 Dec 2007	11.49
FY2006	31 Dec 2006	20.76
FY2005	31 Dec 2005	8.68
FY2004	31 Dec 2004	10.97
FY2003	31 Dec 2003	11.89
FY2002	31 Dec 2002	10.05
FY2001	31 Dec 2001	25.07
FY2000	31 Dec 2000	12.10
FY1999	31 Dec 1999	10.26
FY1998	31 Dec 1998	14.51
FY1997	31 Dec 1997	10.90
FY1996	31 Dec 1996	9.43
FY1995	31 Dec 1995	8.82
FY1994	31 Dec 1994	7.85
FY1993	31 Dec 1993	7.89
FY1992	31 Dec 1992	9.23
FY1991	31 Dec 1991	12.09
FY1990	31 Dec 1990	9.04
FY1989	31 Dec 1989	7.94
FY1988	31 Dec 1988	6.43
FY1987	31 Dec 1987	7.74
FY1986	31 Dec 1986	8.83
FY1985	31 Dec 1985	7.68

Quarter	Period ending	P/E ratio
Q3 FY2026	30 Sept 2026	36.54
Q2 FY2026	30 Jun 2026	29.15
Q1 FY2026	31 Mar 2026	28.58
Q4 FY2025	31 Dec 2025	33.55
Q3 FY2025	30 Sept 2025	16.76
Q2 FY2025	30 Jun 2025	16.93
Q1 FY2025	31 Mar 2025	17.17
Q4 FY2024	31 Dec 2024	14.62
Q3 FY2024	30 Sept 2024	34.29
Q2 FY2024	30 Jun 2024	32.20
Q1 FY2024	31 Mar 2024	34.52
Q4 FY2023	31 Dec 2023	33.35
Q3 FY2023	30 Sept 2023	32.62
Q2 FY2023	30 Jun 2023	36.76
Q1 FY2023	31 Mar 2023	30.39
Q4 FY2022	31 Dec 2022	27.52
Q3 FY2022	30 Sept 2022	21.40
Q2 FY2022	30 Jun 2022	22.24
Q1 FY2022	31 Mar 2022	26.83
Q4 FY2021	31 Dec 2021	35.11
Q3 FY2021	30 Sept 2021	28.84
Q2 FY2021	30 Jun 2021	32.23
Q1 FY2021	31 Mar 2021	37.20
Q4 FY2020	31 Dec 2020	43.14
Q3 FY2020	30 Sept 2020	57.03
Q2 FY2020	30 Jun 2020	52.05
Q1 FY2020	31 Mar 2020	39.00
Q4 FY2019	31 Dec 2019	41.52
Q3 FY2019	30 Sept 2019	44.95
Q2 FY2019	30 Jun 2019	51.58
Q1 FY2019	31 Mar 2019	53.60
Q4 FY2018	31 Dec 2018	53.62
Q3 FY2018	30 Sept 2018	146.93
Q2 FY2018	30 Jun 2018	115.55
Q1 FY2018	31 Mar 2018	220.70
Q4 FY2017	31 Dec 2017	208.61
Q3 FY2017	30 Sept 2017	44.16
Q2 FY2017	30 Jun 2017	72.12
Q1 FY2017	31 Mar 2017	51.27
Q4 FY2016	31 Dec 2016	41.14
Q3 FY2016	30 Sept 2016	46.43
Q2 FY2016	30 Jun 2016	25.88
Q1 FY2016	31 Mar 2016	25.57
Q4 FY2015	31 Dec 2015	41.78
Q3 FY2015	30 Sept 2015	34.82
Q2 FY2015	30 Jun 2015	43.06
Q1 FY2015	31 Mar 2015	49.98
Q4 FY2014	31 Dec 2014	29.72
Q3 FY2014	30 Sept 2014	31.80
Q2 FY2014	30 Jun 2014	25.67
Q1 FY2014	31 Mar 2014	24.04
Q4 FY2013	31 Dec 2013	23.04
Q3 FY2013	30 Sept 2013	16.88
Q2 FY2013	30 Jun 2013	13.55
Q1 FY2013	31 Mar 2013	10.45
Q4 FY2012	31 Dec 2012	8.19
Q3 FY2012	30 Sept 2012	8.00
Q2 FY2012	30 Jun 2012	9.90
Q1 FY2012	31 Mar 2012	9.03
Q4 FY2011	31 Dec 2011	8.95
Q3 FY2011	30 Sept 2011	8.38
Q2 FY2011	30 Jun 2011	7.63
Q1 FY2011	31 Mar 2011	8.13
Q4 FY2010	31 Dec 2010	7.70
Q3 FY2010	30 Sept 2010	8.18
Q2 FY2010	30 Jun 2010	6.52
Q1 FY2010	31 Mar 2010	7.33
Q4 FY2009	31 Dec 2009	6.94
Q3 FY2009	30 Sept 2009	6.56
Q2 FY2009	30 Jun 2009	6.71
Q1 FY2009	31 Mar 2009	6.74
Q4 FY2008	31 Dec 2008	8.34
Q3 FY2008	30 Sept 2008	9.36
Q2 FY2008	30 Jun 2008	9.33
Q1 FY2008	31 Mar 2008	10.59
Q4 FY2007	31 Dec 2007	11.50
Q3 FY2007	30 Sept 2007	21.15
Q2 FY2007	30 Jun 2007	20.51
Q1 FY2007	31 Mar 2007	26.53
Q4 FY2006	31 Dec 2006	20.91
Q3 FY2006	30 Sept 2006	11.21
Q2 FY2006	30 Jun 2006	10.15
Q1 FY2006	31 Mar 2006	9.15
Q4 FY2005	31 Dec 2005	8.56
Q3 FY2005	30 Sept 2005	9.34
Q2 FY2005	30 Jun 2005	10.42
Q1 FY2005	31 Mar 2005	10.88
Q4 FY2004	31 Dec 2004	10.94
Q3 FY2004	30 Sept 2004	10.05
Q2 FY2004	30 Jun 2004	9.81
Q1 FY2004	31 Mar 2004	10.40
Q4 FY2003	31 Dec 2003	11.89
Q3 FY2003	30 Sept 2003	12.27
Q2 FY2003	30 Jun 2003	12.83
Q1 FY2003	31 Mar 2003	9.64
Q4 FY2002	31 Dec 2002	10.06
Q3 FY2002	30 Sept 2002	10.21
Q2 FY2002	30 Jun 2002	9.73
Q1 FY2002	31 Mar 2002	14.19
Q4 FY2001	31 Dec 2001	25.19
Q3 FY2001	30 Sept 2001	21.78
Q2 FY2001	30 Jun 2001	19.52
Q1 FY2001	31 Mar 2001	17.56
Q4 FY2000	31 Dec 2000	12.09
Q3 FY2000	30 Sept 2000	12.25
Q2 FY2000	30 Jun 2000	12.35
Q1 FY2000	31 Mar 2000	9.91
Q4 FY1999	31 Dec 1999	10.34
Q3 FY1999	30 Sept 1999	10.55
Q2 FY1999	30 Jun 1999	12.69
Q1 FY1999	31 Mar 1999	13.38
Q4 FY1998	31 Dec 1998	14.33
Q3 FY1998	30 Sept 1998	13.06
Q2 FY1998	30 Jun 1998	12.70
Q1 FY1998	31 Mar 1998	11.91
Q4 FY1997	31 Dec 1997	10.74
Q3 FY1997	30 Sept 1997	10.72
Q2 FY1997	30 Jun 1997	11.68
Q1 FY1997	31 Mar 1997	10.24
Q4 FY1996	31 Dec 1996	9.24
Q3 FY1996	30 Sept 1996	9.44
Q2 FY1996	30 Jun 1996	8.50
Q1 FY1996	31 Mar 1996	8.32
Q4 FY1995	31 Dec 1995	8.71
Q3 FY1995	30 Sept 1995	9.28
Q2 FY1995	30 Jun 1995	9.01
Q1 FY1995	31 Mar 1995	8.20
Q4 FY1994	31 Dec 1994	7.73
Q3 FY1994	30 Sept 1994	7.67
Q2 FY1994	30 Jun 1994	7.30
Q1 FY1994	31 Mar 1994	6.89
Q4 FY1993	31 Dec 1993	7.77
Q3 FY1993	30 Sept 1993	7.54
Q2 FY1993	30 Jun 1993	7.19
Q1 FY1993	31 Mar 1993	7.38
Q4 FY1992	31 Dec 1992	9.07
Q3 FY1992	30 Sept 1992	8.64
Q2 FY1992	30 Jun 1992	9.48
Q1 FY1992	31 Mar 1992	9.93
Q4 FY1991	31 Dec 1991	11.62
Q3 FY1991	30 Sept 1991	9.65
Q2 FY1991	30 Jun 1991	9.67
Q1 FY1991	31 Mar 1991	8.99
Q4 FY1990	31 Dec 1990	8.88
Q3 FY1990	30 Sept 1990	8.43
Q2 FY1990	30 Jun 1990	8.65
Q1 FY1990	31 Mar 1990	7.22
Q4 FY1989	31 Dec 1989	7.83
Q3 FY1989	30 Sept 1989	7.72
Q2 FY1989	30 Jun 1989	7.28
Q1 FY1989	31 Mar 1989	8.08
Q4 FY1988	31 Dec 1988	7.33
Q3 FY1988	30 Sept 1988	6.78
Q2 FY1988	30 Jun 1988	6.59
Q1 FY1988	31 Mar 1988	7.18
Q4 FY1987	31 Dec 1987	7.75
Q3 FY1987	30 Sept 1987	10.02
Q2 FY1987	30 Jun 1987	11.08
Q1 FY1987	31 Mar 1987	11.08
Q4 FY1986	31 Dec 1986	8.64
Q3 FY1986	30 Sept 1986	8.47
Q2 FY1986	30 Jun 1986	11.23
Q1 FY1986	31 Mar 1986	—
Q4 FY1985	31 Dec 1985	—
Q3 FY1985	30 Sept 1985	—

Common questions about Abbott Laboratories's P/E ratio

Source: Financial Modeling Prep

Abbott Laboratories
D
Quotes are delayed by 15 minutes

ABT

Abbott Laboratories P/E ratio

Is Abbott Laboratories's P/E high compared with its own history?

The price against its P/E range

Growth a year: the past against what analysts expect

What changed in 5 years

P/E ratio by year and by quarter

Common questions about Abbott Laboratories's P/E ratio

What is Abbott Laboratories's P/E ratio?

Is Abbott Laboratories's P/E ratio high or low?

What is Abbott Laboratories's forward P/E?

What is Abbott Laboratories's PEG ratio?

Need help?

Abbott Laboratories DQuotes are delayed by 15 minutes

ABT

Abbott Laboratories P/E ratio

Is Abbott Laboratories's P/E high compared with its own history?

P/E ratio by year and by quarter

Common questions about Abbott Laboratories's P/E ratio

What is Abbott Laboratories's P/E ratio?

Is Abbott Laboratories's P/E ratio high or low?

What is Abbott Laboratories's forward P/E?

What is Abbott Laboratories's PEG ratio?

Need help?

Abbott Laboratories
D
Quotes are delayed by 15 minutes